GSK
GlaxoSmithKline PLC
50.50$
+0.3%
vs. previous close
Closing price · As of: Aug 13, 2026
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 16 | Q4 16 | Q1 17 | Q2 17 | Q3 17 | Q4 17 | Q1 18 | Q2 18 | Q3 18 | Q4 18 | Q1 19 | Q2 19 | Q3 19 | Q4 19 | Q1 20 | Q2 20 | Q3 20 | Q4 20 | Q1 21 | Q2 21 | Q3 21 | Q4 21 | Q1 22 | Q2 22 | Q3 22 | Q4 22 | Q1 23 | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | +0.6% | -2.7% | -0.9% | +7.1% | -2.6% | -5.5% | +1.2% | +10.7% | +1.3% | -6.5% | +1.9% | +20.2% | -5.2% | +2.1% | -16.1% | +13.4% | +1.1% | -15.1% | -21.3% | +13.5% | +43.8% | -24.5% | -3.6% | +13.0% | -5.8% | -5.8% | +3.3% | +13.5% | -1.2% | -8.6% | +7.1% | +1.6% | +1.3% | -7.4% | +6.3% | +7.0% | +0.8% | -11.5% | +10.2% | – | |
| – | -0.7% | +0.2% | +4.2% | +1.3% | -3.5% | -6.5% | -3.4% | +14.1% | +10.2% | -5.9% | -3.5% | +23.1% | +0.1% | -1.5% | -23.4% | +17.8% | +9.9% | -21.8% | -31.1% | +18.0% | +82.5% | -26.2% | -19.9% | +11.4% | -7.6% | -13.2% | -0.6% | +17.6% | +6.4% | -18.5% | +7.7% | +13.0% | +6.8% | -24.3% | +11.8% | +4.3% | +17.7% | -29.4% | +20.9% | – | |
| – | +1.2% | -4.1% | -3.5% | +10.4% | -2.1% | -4.9% | +3.5% | +9.1% | -3.0% | -6.9% | +5.0% | +18.7% | -8.0% | +4.2% | -12.2% | +11.3% | -3.4% | -11.3% | -16.4% | +11.6% | +26.8% | -23.5% | +6.3% | +13.7% | -5.0% | -2.5% | +4.8% | +12.0% | -4.1% | -4.3% | +6.8% | -2.6% | -1.0% | +0.4% | +4.3% | +8.0% | -5.2% | -3.5% | +6.8% | – | |
| – | +8.8% | -4.3% | +31.3% | -16.9% | +15.5% | -25.2% | +2.3% | +6.8% | +8.9% | -6.5% | +10.6% | +8.4% | +3.1% | -4.5% | +9.6% | -12.4% | +28.9% | -23.9% | +4.4% | +21.3% | +2.3% | -23.8% | +12.6% | +8.4% | +33.5% | -29.9% | +6.4% | +17.4% | +30.0% | -29.9% | +3.0% | -1.2% | +39.2% | -28.0% | +38.4% | -16.6% | +39.1% | -28.0% | +104.8% | – | |
| – | +18.3% | -9.6% | -3.0% | -3.0% | +9.7% | -8.8% | +6.3% | +2.8% | +3.7% | -5.5% | +4.6% | +11.7% | +19.1% | -15.3% | -7.1% | -1.5% | +18.5% | -23.2% | -30.4% | -0.6% | +94.2% | -44.4% | +14.0% | -0.5% | +18.6% | -12.1% | +5.8% | +1.2% | +16.6% | -22.1% | +18.1% | +54.2% | -29.9% | -22.3% | +3.4% | +4.6% | +17.9% | -19.7% | +3.9% | – | |
| – | +25.0% | -29.7% | +49.7% | -29.8% | +37.9% | -21.4% | +17.5% | -16.0% | +5.4% | -6.4% | +5.4% | +8.3% | -6.1% | +3.4% | -40.0% | +67.9% | +15.5% | -28.0% | -12.0% | +13.2% | +53.3% | -56.0% | +68.4% | +14.8% | -22.4% | -10.5% | +6.1% | +26.4% | +28.9% | -22.9% | +5.5% | +31.8% | -10.4% | -30.8% | +12.9% | -2.7% | +20.5% | -22.3% | +63.6% | – | |
| – | -58.4% | +188.7% | -101.2% | – | -72.7% | +142.2% | -37.2% | +145.2% | -18.6% | -8.1% | +3.9% | +44.7% | -11.4% | +5.9% | +41.5% | -34.8% | -42.9% | +59.6% | -24.7% | +8.2% | -35.1% | +156.2% | -52.9% | +10.2% | +56.8% | +11.5% | +2.8% | -9.0% | -70.6% | +160.0% | +10.5% | -88.5% | +268.3% | +218.4% | -8.7% | +28.2% | -41.9% | +52.3% | -79.0% | – | |
| – | +8.5% | -0.1% | -1.0% | +1.0% | -20.6% | +5.2% | +19.8% | +20.1% | -9.0% | +5.6% | +5.8% | +3.4% | -15.9% | +11.2% | +0.0% | -13.5% | +17.1% | -13.3% | -4.5% | +1.6% | -3.7% | +9.1% | -0.5% | -2.0% | +29.1% | -21.4% | -8.9% | -1.6% | +51.3% | -39.7% | +4.8% | -10.3% | -7.7% | +12.5% | +13.6% | -9.2% | +4.2% | -4.0% | +9.0% | – | |
| – | -66.8% | +266.4% | -111.5% | – | -74.2% | +150.5% | -44.5% | +177.7% | -19.4% | -5.7% | -2.4% | +54.4% | -12.3% | +7.2% | +43.9% | -36.7% | -50.9% | +84.9% | -29.5% | +11.4% | -40.8% | +196.6% | -57.2% | +12.9% | +60.7% | +17.3% | +4.2% | -9.9% | -78.8% | +257.5% | +10.3% | -95.7% | +779.7% | +274.4% | -10.5% | +30.2% | -61.3% | +125.7% | -83.5% | – | |
| – | -72.8% | +208.5% | -128.1% | – | +154.7% | -56.8% | -60.1% | +38.8% | -61.7% | +318.9% | -31.0% | +9.8% | -17.4% | -19.6% | +28.8% | +19.9% | -107.5% | – | -177.9% | – | -191.1% | – | -53.6% | +55.3% | -99.6% | +27,500.0% | -12.3% | +6.2% | -107.4% | – | -30.3% | -100.5% | – | +441.9% | -28.3% | +29.5% | -28.5% | +36.8% | -165.2% | – | |
| – | -68.2% | +307.0% | -117.2% | – | -145.0% | – | -19.7% | +221.5% | -14.3% | -31.7% | +16.1% | +61.0% | -16.3% | +20.5% | +44.6% | -45.0% | -45.6% | +58.5% | +30.0% | -1.9% | -45.2% | +140.6% | -53.5% | +1,191.3% | -86.5% | +2.0% | +9.0% | -9.9% | -76.1% | +198.9% | +12.1% | -104.9% | – | +292.3% | -11.1% | +39.5% | -68.4% | +173.1% | -75.0% | – | |
| – | -25.7% | +69.5% | -46.8% | +135.1% | -83.6% | +312.0% | -42.6% | +142.7% | -7.8% | +20.5% | -15.7% | +19.0% | -14.0% | -3.1% | +35.7% | -18.1% | +29.0% | -35.8% | -13.3% | +27.3% | -45.3% | +116.3% | -25.8% | +7.5% | +5.4% | +20.4% | -4.6% | -2.7% | -54.7% | +78.9% | +11.5% | -49.3% | -4.4% | +176.4% | +4.4% | +4.1% | -43.3% | +45.5% | +1.9% | – |
LTM = last twelve months (sum of the four most recent quarters).
Showing the most recent 40 periods — older statements are on file for this stock.
Data as of: August 13, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.